Evidence map›Paper›PMID 37187302›Full record

ArticleActa biomaterialia2023

Reduction of neutrophil extracellular traps accelerates inflammatory resolution and increases bone formation on titanium implants.

Lais Morandini, Derek Avery, Benjamin Angeles, Paul Winston, Rebecca K Martin, Henry J Donahue, Rene Olivares-Navarrete

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Equine adipose-derived stem cells modulateFrontiers in veterinary science · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lais MorandiniDepartment of Biomedical Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Derek AveryDepartment of Biomedical Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Benjamin AngelesDepartment of Biomedical Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Paul WinstonDepartment of Biomedical Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Rebecca K MartinDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Henry J DonahueDepartment of Biomedical Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA, United States.
Rene Olivares-NavarreteDepartment of Biomedical Engineering, College of Engineering, Virginia Commonwealth University, Richmond, VA, United States. Electronic address: ronavarrete@vcu.edu.
Virginia Commonwealth University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
Role of Wnt Signaling in Macrophage Response to BiomaterialsR01DE028919 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI OLIVARES-NAVARRETE, RENE · 2019 to 2023
$1.8M
NCI NIH HHS P30 CA016059NIDCR NIH HHS R01 DE028919
6 · The paper itself

Abstract

Neutrophils are the most abundant immune cells in the blood and the first cells to be recruited to the biomaterial implantation site. Neutrophils are fundamental in recruiting mononuclear leukocytes to mount an immune response at the injury site. Neutrophils exert significant pro-inflammatory effects through the release of cytokines and chemokines, degranulation and release of myeloperoxidase (MPO) and neutrophil elastase (NE), and the production of large DNA-based networks called neutrophil extracellular traps (NETs). Neutrophils are initially recruited and activated by cytokines and pathogen- and damage-associated molecular patterns, but little is known about how the physicochemical composition of the biomaterial affects their activation. This study aimed to understand how ablating neutrophil mediators (MPO, NE, NETs) affected macrophage phenotype in vitro and osseointegration in vivo. We discovered that NET formation is a crucial mediator of pro-inflammatory macrophage activation, and inhibition of NET formation significantly suppresses macrophage pro-inflammatory phenotype. Furthermore, reducing NET formation accelerated the inflammatory phase of healing and produced greater bone formation around the implanted biomaterial, suggesting that NETs are essential regulators of biomaterial integration. Our findings emphasize the importance of the neutrophil response to implanted biomaterials and highlight innate immune cells' regulation and amplification signaling during the initiation and resolution of the inflammatory phase of biomaterial integration. STATEMENT OF SIGNIFICANCE: Neutrophils are the most abundant immune cells in blood and are the first to be recruited to the injury/implantation site where they exert significant pro-inflammatory effects. This study aimed to understand how ablating neutrophil mediators affected macrophage phenotype in vitro and bone apposition in vivo. We found that NET formation is a crucial mediator of pro-inflammatory macrophage activation. Reducing NET formation accelerated the inflammatory phase of healing and produced greater appositional bone formation around the implanted biomaterial, suggesting that NETs are essential regulators of biomaterial integration.

Indexed as

Extracellular TrapsBiocompatible MaterialsCytokinesNeutrophilsOsteogenesisTitaniumBiocompatible MaterialsCytokinesTitaniumInflammationMacrophagesNeutrophilsTitanium

Identifiers

PMID37187302
PMCPMC10330750
OpenAlexW4376505768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.